Steady state study for Carbamazepine [Study Per­for­mance]

posted by labanya – 2009-02-27 14:28 (6331 d 20:39 ago) – Posting: # 3296
Views: 7,559

Hi,

We are planning to conduct a steady state BE study for carbamazepine extended release tablet of the highest dose. I would like to know:
First will the metabolite be analysed in this case?
Second if any tablet gets missed or the subject vomits after dosing then will the subject be withdrwan from the study?

Thanks

Complete thread:

UA Flag
Activity
 Admin contact
23,656 posts in 4,994 threads, 1,570 registered users;
260 visitors (0 registered, 260 guests [including 17 identified bots]).
Forum time: 12:07 CEST (Europe/Vienna)

It requires a very unusual mind
to undertake the analysis of the obvious.    Alfred North Whitehead

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5